ANIX

Anixa Biosciences Inc

Jun 17 • 04:00PM ET

2.69

+0.08 3.07 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	5.38%	Shs Outstand	33.92M	Perf Week	14.47%
Market Cap	91.52M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	1.88%	Shs Float	32.19M	Perf Month	-2.54%
Enterprise Value	76.76M	PEG	-	EPS next Q	-0.09	Inst Own	14.97%	Short Float	3.15%	Perf Quarter	-2.89%
Income	-10.03M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.95%	Short Ratio	8.45	Perf Half Y	-17.48%
Sales	0.00M	P/B	6.30	EPS next Y	-4.48%	ROA	-63.02%	Short Interest	1.01M	Perf YTD	-13.78%
Book/sh	0.43	P/C	6.69	EPS next 5Y	-3.32%	ROE	-65.70%	52W High	5.46 -50.70%	Perf Year	-26.90%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-68.66%	52W Low	2.32 15.95%	Perf 3Y	-20.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.73% 5.93%	Perf 5Y	-34.87%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.64%	Oper. Margin	-	ATR (14)	0.16	Perf 10Y	-19.37%
Dividend Ex-Date	-	Quick Ratio	9.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	52.92	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.79	EPS Q/Q	13.51%	SMA20	3.74%	Beta	0.60	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-3.67%	Rel Volume	2.10	Prev Close	2.61
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-18.58%	Avg Volume	119.94K	Price	2.69
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	245,253	Change	3.07%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)